These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 31420496

  • 1. 18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies.
    Davenport MS, Montgomery JS, Kunju LP, Siddiqui J, Shankar PR, Rajendiran T, Shao X, Lee E, Denton B, Barnett C, Piert M.
    J Nucl Med; 2020 Mar; 61(3):337-343. PubMed ID: 31420496
    [Abstract] [Full Text] [Related]

  • 2. 18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis.
    Barnett CL, Davenport MS, Montgomery JS, Kunju LP, Denton BT, Piert M.
    J Nucl Med; 2019 Dec; 60(12):1705-1712. PubMed ID: 31350321
    [Abstract] [Full Text] [Related]

  • 3. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M, Montgomery J, Kunju LP, Siddiqui J, Rogers V, Rajendiran T, Johnson TD, Shao X, Davenport MS.
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [Abstract] [Full Text] [Related]

  • 4. Multiparametric MRI and 18F-PSMA-1007 PET/CT for the Detection of Clinically Significant Prostate Cancer.
    Privé BM, Israël B, Janssen MJR, van der Leest MMG, de Rooij M, van Ipenburg JA, Jonker M, Peters SMB, de Groot M, Zámecnik P, Hoepping A, Bomers JG, Gotthardt M, Sedelaar JPM, Barentsz JO, van Oort IM, Nagarajah J.
    Radiology; 2024 May; 311(2):e231879. PubMed ID: 38771185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
    Stabile A, Dell'Oglio P, De Cobelli F, Esposito A, Gandaglia G, Fossati N, Brembilla G, Cristel G, Cardone G, Deho' F, Losa A, Suardi N, Gaboardi F, Del Maschio A, Montorsi F, Briganti A.
    Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
    [Abstract] [Full Text] [Related]

  • 7. Prospective analysis of clinically significant prostate cancer detection with [18F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.
    Bodar YJL, Zwezerijnen BGJC, van der Voorn PJ, Jansen BHE, Smit RS, Kol SQ, Meijer D, de Bie K, Yaqub M, Windhorst BAD, Hendrikse HNH, Vis AN, Oprea-Lager DE.
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1731-1742. PubMed ID: 34725727
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
    Chaloupka M, Bischoff R, Pfitzinger P, Lellig E, Ledderose S, Buchner A, Schlenker B, Stief C, Clevert DA, Apfelbeck M.
    Clin Hemorheol Microcirc; 2019 Apr; 73(1):105-111. PubMed ID: 31561351
    [Abstract] [Full Text] [Related]

  • 10. Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
    Singh S, Rogers H, Kanber B, Clemente J, Pye H, Johnston EW, Parry T, Grey A, Dinneen E, Shaw G, Heavey S, Stopka-Farooqui U, Haider A, Freeman A, Giganti F, Atkinson D, Moore CM, Whitaker HC, Alexander DC, Panagiotaki E, Punwani S.
    Radiology; 2022 Dec; 305(3):623-630. PubMed ID: 35916679
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H, Günzel K, Maxeiner A, Stephan C, Fischer T, Durmus T, Miller K, Asbach P, Haas M, Kempkensteffen C.
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [Abstract] [Full Text] [Related]

  • 13. Elucidating the need for prostate cancer risk calculators in conjunction with mpMRI in initial risk assessment before prostate biopsy at a tertiary prostate cancer center.
    Krausewitz P, Büttner T, von Danwitz M, Weiten R, Cox A, Klümper N, Stein J, Luetkens J, Kristiansen G, Ritter M, Ellinger J.
    BMC Urol; 2024 Mar 26; 24(1):71. PubMed ID: 38532370
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
    Van Nieuwenhove S, Saussez TP, Thiry S, Trefois P, Annet L, Michoux N, Lecouvet F, Tombal B.
    BJU Int; 2019 Mar 26; 123(3):411-420. PubMed ID: 30240059
    [Abstract] [Full Text] [Related]

  • 16. MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.
    Sheridan AD, Nath SK, Aneja S, Syed JS, Pahade J, Mathur M, Sprenkle P, Weinreb JC, Spektor M.
    AJR Am J Roentgenol; 2018 May 26; 210(5):W218-W225. PubMed ID: 29489409
    [Abstract] [Full Text] [Related]

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 May 26; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 18. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.
    Franklin A, Yaxley WJ, Raveenthiran S, Coughlin G, Gianduzzo T, Kua B, McEwan L, Wong D, Delahunt B, Egevad L, Samaratunga H, Brown N, Parkinson R, Roberts MJ, Yaxley JW.
    BJU Int; 2021 Jan 26; 127(1):71-79. PubMed ID: 32524748
    [Abstract] [Full Text] [Related]

  • 19. Accuracy of MRI-ultrasound fusion-guided and systematic biopsy of the prostate.
    In de Braekt T, van Rooij SBT, Daniels-Gooszen AW, Scheepens WA, de Jongh R, Bosch SL, Nederend J.
    Br J Radiol; 2024 May 29; 97(1158):1132-1138. PubMed ID: 38627253
    [Abstract] [Full Text] [Related]

  • 20. Characterizing indeterminate (Likert-score 3/5) peripheral zone prostate lesions with PSA density, PI-RADS scoring and qualitative descriptors on multiparametric MRI.
    Brizmohun Appayya M, Sidhu HS, Dikaios N, Johnston EW, Simmons LA, Freeman A, Kirkham AP, Ahmed HU, Punwani S.
    Br J Radiol; 2018 Feb 29; 91(1083):20170645. PubMed ID: 29189042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.